Neuralink Applied for Human Trials in 2022, But the FDA Rejected it—Why?

In a supposed bid to put things underway, Elon Musk's Neuralink got rejected by the US Food and Drug Administration (FDA) in 2022 for its plans to move forward in testing its technology for humans. According to several reports and sources, the company applied for human trials last year but its efforts were hindered as per the agency's rejection.

The good thing here is that Neuralink is doing things by the book and is applying for the progression of its technology from the FDA to carry on with its supposed testing.

Neuralink Got Rejected by the FDA for Human Trials in 2022